Cargando…

The Interplay Between Use of Biological Therapies, Psychological State, and the Microbiome in IBD

BACKGROUND: This study examines longitudinal bio-psychological dynamics and their interplay in IBD patients undergoing conventional and biological therapies. METHODS: Fifty IBD participants (24 UC, 26 CD) in clinical remission were followed for 12 months. Complete longitudinal datasets, biological s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tavakoli, Paris, Vollmer-Conna, Ute, Hadzi-Pavlovic, Dusan, Vázquez-Campos, Xabier, Grimm, Michael Carl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345200/ https://www.ncbi.nlm.nih.gov/pubmed/35928295 http://dx.doi.org/10.3389/fmed.2022.788992

Ejemplares similares

A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration
por: Tavakoli, P., et al.
Publicado: (2021)

The health and well-being of Australia’s future medical doctors: protocol for a 5-year observational cohort study of medical trainees
por: Cvejic, Erin, et al.
Publicado: (2017)

Empathy as a Function of Clinical Exposure - Reading Emotion in the Eyes
por: Handford, Cameron, et al.
Publicado: (2013)

An Impact of Psychological Stress on the Interplay between Salivary Oxidative Stress and the Classic Psychological Stress-Related Parameters
por: Stojanović, Nikola M., et al.
Publicado: (2021)

Feasibility and Effectiveness of a Web-Based Positive Psychology Program for Youth Mental Health: Randomized Controlled Trial
por: Manicavasagar, Vijaya, et al.
Publicado: (2014)

Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials
por: Cleynen, Isabelle, et al.
Publicado: (2019)

Intercontinental Gut Microbiome Variances in IBD
por: Mayorga, Luis, et al.
Publicado: (2022)

Editorial: Current trends and future management of IBD
por: Estevinho, María Manuela, et al.
Publicado: (2023)

Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue
por: Aslakson, Eric, et al.
Publicado: (2009)

Gene Expression in Response to Exercise in Patients with Chronic Fatigue Syndrome: A Pilot Study
por: Keech, Andrew, et al.
Publicado: (2016)

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
por: Gutiérrez, Ana, et al.
Publicado: (2022)

Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?
por: Gomollón, Fernando, et al.
Publicado: (2021)

Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic Review
por: Wang, Yang, et al.
Publicado: (2021)

Editorial: Microbiome in IBD: From Composition to Therapy
por: Zhu, Ruixin, et al.
Publicado: (2021)

Seasonal Clock Changes Are Underappreciated Health Risks—Also in IBD?
por: Föh, Bandik, et al.
Publicado: (2019)

Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
por: Tien, Ni, et al.
Publicado: (2022)

A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells
por: Patra, VijayKumar, et al.
Publicado: (2018)

Modulation of cytokine patterns and microbiome during pregnancy in IBD
por: van der Giessen, Janine, et al.
Publicado: (2020)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD
por: Larabi, Anaïs, et al.
Publicado: (2019)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Psychological reaction to Covid-19 of Italian patients with IBD
por: Savarese, Mariarosaria, et al.
Publicado: (2021)

Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome
por: Beaumont, Alison, et al.
Publicado: (2012)

Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility
por: An, Hongyan, et al.
Publicado: (2016)

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
por: Elmaghrawy, Khalid, et al.
Publicado: (2021)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Intestinal Mucosal Wound Healing and Barrier Integrity in IBD–Crosstalk and Trafficking of Cellular Players
por: Sommer, Katrin, et al.
Publicado: (2021)

Genetic associations of fatigue and other symptom domains of the acute sickness response to infection
por: Piraino, B., et al.
Publicado: (2012)

Prognostic Factors of Biologic Therapy in Pediatric IBD
por: Buczyńska, Anna, et al.
Publicado: (2022)

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study
por: Williams, Astrid-Jane, et al.
Publicado: (2021)

Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
por: Atreya, Raja, et al.
Publicado: (2020)

Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype
por: Gonzalez Acera, Miguel, et al.
Publicado: (2021)

IBD-like Lesions in a Secukinumab-treated Patient
por: Kakizoe, Kozue, et al.
Publicado: (2021)

Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome
por: Sun, Zeyu, et al.
Publicado: (2021)

Acceptance and commitment therapy universal prevention program for adolescents: a feasibility study
por: Burckhardt, Rowan, et al.
Publicado: (2017)

Editorial: Interplay of Infection and Microbiome
por: Huston, Wilhelmina M., et al.
Publicado: (2020)

The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature
por: Nduma, Basil N, et al.
Publicado: (2023)

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study
por: Attauabi, Mohamed, et al.
Publicado: (2022)

OC.10.2 A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION
por: Pisani, L.F., et al.
Publicado: (2022)

S10.3d Yeast Microbiome in patients with inflammatory bowel disease (IBD)
por: Vaezi, Afsane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n9fhm9o8k4b7ssroh321mi2rr2